SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001293971-24-000020
Filing Date
2024-05-09
Accepted
2024-05-09 07:01:50
Documents
14
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20240509.htm   iXBRL 8-K 28542
2 EX-99.1 exhibit99120240509.htm EX-99.1 25593
  Complete submission text file 0001293971-24-000020.txt   185212

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20240509.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20240509_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20240509_pre.xml EX-101.PRE 12516
17 EXTRACTED XBRL INSTANCE DOCUMENT blue-20240509_htm.xml XML 2718
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 24928477
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)